Persistence of Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy
To access this article, please choose from the options below
Conflicts of interest The authors disclose the following: Dr Bajaj is a consultant for and receives independent grant support from Salix and Ocera. Dr Sanyal is a consultant for Salix Pharmaceuticals. The remaining authors disclose no conflicts.
Funding Supported in part by the American College of Gastroenterology Junior Faculty Development Award, and by clinical research center grants MO1-RR00065 and MO1-RR00058, NCRR, and NIH (awarded to J.S.B.).
PII: S0016-5085(10)00206-4
doi:10.1053/j.gastro.2010.02.015
© 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

